IFP Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-86
Closed -$1.37K – 5190
2026
Q1
$1.37K Hold
86
– – ﹤0.01% 4092
2025
Q4
$2.26K Buy
+86
New +$2.23K ﹤0.01% 3793
2025
Q2
– Hold
0
– – – 4428
2025
Q1
– Sell
-44
Closed -$749 – 3808
2024
Q4
$1.07K Buy
+44
New +$859 ﹤0.01% 3261
2024
Q2
– Sell
-185
Closed -$4.01K – 3266
2024
Q1
$4.01K Sell
185
-50
-21% -$1.24K ﹤0.01% 2521
2023
Q4
$6.79K Hold
235
– – ﹤0.01% 2317
2023
Q3
$6.28K Hold
235
– – ﹤0.01% 2426
2023
Q2
$8.7K Buy
235
+50
+27% +$1.74K ﹤0.01% 2349
2023
Q1
$718 Sell
185
-13
-7% -$418 ﹤0.01% 3136
2022
Q4
$2K Sell
198
-13
-6% -$465 ﹤0.01% 4153
2022
Q3
$2K Hold
211
– – ﹤0.01% 4349
2022
Q2
$2K Hold
211
– – ﹤0.01% 4118
2022
Q1
$2K Buy
211
+26
+14% +$1.71K ﹤0.01% 4116
2021
Q4
$19K Sell
185
-102
-36% -$8.96K ﹤0.01% 1966
2021
Q3
$26K Buy
287
+135
+89% +$12.3K ﹤0.01% 1872
2021
Q2
$14K Hold
152
– – ﹤0.01% 2081
2021
Q1
$15K Buy
152
+74
+95% +$7.64K ﹤0.01% 1963
2020
Q4
$4K Buy
+78
New +$3.26K ﹤0.01% 2402

Other funds holding FLGT

IFP Advisors's FLGT Position: Q2 2026 in Review

IFP Advisors sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 86 shares — an estimated $1.37K sold.

IFP Advisors first reported a position in FLGT in Q4 2020 and held it in 17 quarters. The position peaked at $26K in Q3 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • IFP Advisors reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 86 Fulgent Genetics shares in Q2 2026, an estimated $1.37K.
  • IFP Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 17 quarters.
  • IFP Advisors's Fulgent Genetics position peaked at $26K in Q3 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.